Your browser doesn't support javascript.
loading
Alternative mRNA splicing in cancer immunotherapy.
Frankiw, Luke; Baltimore, David; Li, Guideng.
Afiliação
  • Frankiw L; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
  • Baltimore D; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. baltimo@caltech.edu.
  • Li G; Center of Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. lgd@ism.cams.cn.
Nat Rev Immunol ; 19(11): 675-687, 2019 11.
Article em En | MEDLINE | ID: mdl-31363190
ABSTRACT
Immunotherapies are yielding effective treatments for several previously untreatable cancers. Still, the identification of suitable antigens specific to the tumour that can be targets for cancer vaccines and T cell therapies is a challenge. Alternative processing of mRNA, a phenomenon that has been shown to alter the proteomic diversity of many cancers, may offer the potential of a broadened target space. Here, we discuss the promise of analysing mRNA processing events in cancer cells, with an emphasis on mRNA splicing, for the identification of potential new targets for cancer immunotherapy. Further, we highlight the challenges that must be overcome for this new avenue to have clinical applicability.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Processamento Alternativo / Imunoterapia / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Processamento Alternativo / Imunoterapia / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article